Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

With all the hype around AI, business partners and legal professionals are scrambling to understand, adapt, and possibly implement the ...

The general mood among these heavyweight investors is divided, with 41% leaning bullish and 41% bearish. Among these notable options, 3 are puts, totaling $371,983, and 9 are calls, amounting to ...

Icarus Behavioral Health Nevada announces the accreditation of its comprehensive mental health programs in Las Vegas, ...

Cigna Group inc. (NYSE: CI) shares are rebounding Friday after dropping on Thursday following a fourth-quarter earnings miss.

The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.

California is leading the way in ensuring that determinations of medically necessary health care services are made by licensed physicians and ...

Raymond James analyst John Ransom lowered the firm’s price target on Cigna (CI) to $360 from $415 and keeps a Strong Buy rating on the shares.

CEO David Cordani suggested Thursday that the moves are a direct response to the slaying of UnitedHealthcare CEO Brian Thompson and the public outcry over the state of health care. Other news is on ...

The victim count from last year's data breach has increased significantly. The number of victims impacted by the Change ...

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...

Cigna Corp (NYSE:CI) reported its fourth-quarter 2024 earnings, revealing a notable miss on earnings per share (EPS) despite surpassing revenue expectations. The company's stock reacted negatively in ...